_id
691847bf3c536f8df231785f
Ticker
ZURA
Name
Zura Bio Limited Class A Ordinary Shares
Exchange
NASDAQ
Address
1489 W. Warm Springs Road, Henderson, NV, United States, 89014
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://zurabio.com
Description
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33 to prevent ST2-dependent and ST2-independent inflammation, which has completed Phase 1/2 clinical studies; and Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor alpha chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways, which has completed Phase 1/1b clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Last Close
4.87
Volume
743685
Current Price
5.28
Change
0.45
Last Updated
2026-01-08T13:25:10.452Z
Image
https://logo.clearbit.com/zurabio.com
Ipo Date
2021-09-03T00:00:00.000Z
Market Cap
343323072
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.989
Sentiment Sources
1
Rating
4.5714
Target Price
15.6
Strong Buy
5
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
14000
Gross Profit
-14000
Operating Expenses
19519000
Operating Income
-19519000
Interest Expense
-
Pretax Income
-18040000
Net Income
-20037000
Eps
-0.21188682889391458
Dividends Per Share
-
Shares Outstanding
65023308
Income Tax Expense
1997000
EBITDA
-18026000
Operating Margin
-
Total Other Income Expense Net
1479000
Cash
139017000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
142292000
Property Plant Equipment
131000
Total Assets
143935000
Payables
3275000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
25491000
Equity
108243000
Bs_currency_symbol
USD
Depreciation
14000
Change In Working Capital
197000
Cash From Operations
-15444000
Capital Expenditures
31999
Cash From Investing
-32000
Cash From Financing
3000
Net Change In Cash
-15473000
Cf_currency_symbol
USD
PE
-
PB
4.612781029350629
ROE
-18.511127740361964
ROA
-13.920867058047035
FCF
-15475999
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
14000
Quarters > 0 > income Statement > gross Profit
-14000
Quarters > 0 > income Statement > operating Expenses
19519000
Quarters > 0 > income Statement > operating Income
-19519000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-18040000
Quarters > 0 > income Statement > net Income
-20037000
Quarters > 0 > income Statement > eps
-0.21188682889391458
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
94564632
Quarters > 0 > income Statement > income Tax Expense
1997000
Quarters > 0 > income Statement > EBITDA
-18026000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1479000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
139017000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
142292000
Quarters > 0 > balance Sheet > property Plant Equipment
131000
Quarters > 0 > balance Sheet > total Assets
143935000
Quarters > 0 > balance Sheet > payables
3275000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
25491000
Quarters > 0 > balance Sheet > equity
108243000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-20037000
Quarters > 0 > cash Flow > depreciation
14000
Quarters > 0 > cash Flow > change In Working Capital
197000
Quarters > 0 > cash Flow > cash From Operations
-15444000
Quarters > 0 > cash Flow > capital Expenditures
31999
Quarters > 0 > cash Flow > cash From Investing
-32000
Quarters > 0 > cash Flow > cash From Financing
3000
Quarters > 0 > cash Flow > net Change In Cash
-15473000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.21188682889391458
Quarters > 0 > ratios > PB
4.612781029350629
Quarters > 0 > ratios > ROE
-18.511127740361964
Quarters > 0 > ratios > ROA
-13.920867058047035
Quarters > 0 > ratios > FCF
-15475999
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
11000
Quarters > 1 > income Statement > gross Profit
-11000
Quarters > 1 > income Statement > operating Expenses
18062000
Quarters > 1 > income Statement > operating Income
-18062000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-15993000
Quarters > 1 > income Statement > net Income
-15993000
Quarters > 1 > income Statement > eps
-0.16961510024705284
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
94289954
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-18051000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2069000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
154490000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
156985000
Quarters > 1 > balance Sheet > property Plant Equipment
122000
Quarters > 1 > balance Sheet > total Assets
157805000
Quarters > 1 > balance Sheet > payables
1205000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
18696000
Quarters > 1 > balance Sheet > equity
125905000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-15993000
Quarters > 1 > cash Flow > depreciation
11000
Quarters > 1 > cash Flow > change In Working Capital
-3823000
Quarters > 1 > cash Flow > cash From Operations
-16030000
Quarters > 1 > cash Flow > capital Expenditures
15000
Quarters > 1 > cash Flow > cash From Investing
-15000
Quarters > 1 > cash Flow > cash From Financing
-34000
Quarters > 1 > cash Flow > net Change In Cash
-16079000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.16961510024705284
Quarters > 1 > ratios > PB
3.954179398117629
Quarters > 1 > ratios > ROE
-12.702434375124103
Quarters > 1 > ratios > ROA
-10.134659865023288
Quarters > 1 > ratios > FCF
-16045000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
37
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
9000
Quarters > 2 > income Statement > gross Profit
-9000
Quarters > 2 > income Statement > operating Expenses
19254000
Quarters > 2 > income Statement > operating Income
-19254000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-17442000
Quarters > 2 > income Statement > net Income
-17442000
Quarters > 2 > income Statement > eps
-0.26711577401343933
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
65297529
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-19245000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1812000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
170569000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
171692000
Quarters > 2 > balance Sheet > property Plant Equipment
106000
Quarters > 2 > balance Sheet > total Assets
172496000
Quarters > 2 > balance Sheet > payables
1249000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
21092000
Quarters > 2 > balance Sheet > equity
138200000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-17442000
Quarters > 2 > cash Flow > depreciation
9000
Quarters > 2 > cash Flow > change In Working Capital
2702000
Quarters > 2 > cash Flow > cash From Operations
-11063000
Quarters > 2 > cash Flow > capital Expenditures
49000
Quarters > 2 > cash Flow > cash From Investing
-49000
Quarters > 2 > cash Flow > cash From Financing
5183000
Quarters > 2 > cash Flow > net Change In Cash
-5929000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.26711577401343933
Quarters > 2 > ratios > PB
2.4947246969609265
Quarters > 2 > ratios > ROE
-12.620839363241679
Quarters > 2 > ratios > ROA
-10.11153881829144
Quarters > 2 > ratios > FCF
-11112000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2000
Quarters > 3 > income Statement > cost Of Revenue
5000
Quarters > 3 > income Statement > gross Profit
-5000
Quarters > 3 > income Statement > operating Expenses
15727000
Quarters > 3 > income Statement > operating Income
-15732000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-13625000
Quarters > 3 > income Statement > net Income
-9048000
Quarters > 3 > income Statement > eps
-0.13856573347515186
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
65297529
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-13620000
Quarters > 3 > income Statement > operating Margin
-786600
Quarters > 3 > income Statement > total Other Income Expense Net
2107000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
176498000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
178744000
Quarters > 3 > balance Sheet > property Plant Equipment
91000
Quarters > 3 > balance Sheet > total Assets
179533000
Quarters > 3 > balance Sheet > payables
733000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
19514000
Quarters > 3 > balance Sheet > equity
146815000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-11288000
Quarters > 3 > cash Flow > depreciation
5000
Quarters > 3 > cash Flow > change In Working Capital
-25000
Quarters > 3 > cash Flow > cash From Operations
-10824000
Quarters > 3 > cash Flow > capital Expenditures
45000
Quarters > 3 > cash Flow > cash From Investing
-45000
Quarters > 3 > cash Flow > cash From Financing
-854000
Quarters > 3 > cash Flow > net Change In Cash
-11723000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.13856573347515186
Quarters > 3 > ratios > PB
2.3483360223410417
Quarters > 3 > ratios > ROE
-6.1628580185948305
Quarters > 3 > ratios > ROA
-5.039741997292977
Quarters > 3 > ratios > FCF
-10869000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-5434.5
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
9000
Annuals > 0 > income Statement > gross Profit
-9000
Annuals > 0 > income Statement > operating Expenses
55189000
Annuals > 0 > income Statement > operating Income
-55189000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-52403000
Annuals > 0 > income Statement > net Income
-52403000
Annuals > 0 > income Statement > eps
-0.6980480722714401
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
75070761
Annuals > 0 > income Statement > income Tax Expense
-7017000
Annuals > 0 > income Statement > EBITDA
-55180000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
2786000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
176498000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
178744000
Annuals > 0 > balance Sheet > property Plant Equipment
91000
Annuals > 0 > balance Sheet > total Assets
179533000
Annuals > 0 > balance Sheet > payables
733000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
19514000
Annuals > 0 > balance Sheet > equity
146815000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-52403000
Annuals > 0 > cash Flow > depreciation
9000
Annuals > 0 > cash Flow > change In Working Capital
2307000
Annuals > 0 > cash Flow > cash From Operations
-28076000
Annuals > 0 > cash Flow > capital Expenditures
75000
Annuals > 0 > cash Flow > cash From Investing
-5075000
Annuals > 0 > cash Flow > cash From Financing
109843000
Annuals > 0 > cash Flow > net Change In Cash
76692000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.6980480722714401
Annuals > 0 > ratios > PB
2.699816899363144
Annuals > 0 > ratios > ROE
-35.693219357695064
Annuals > 0 > ratios > ROA
-29.188505734321822
Annuals > 0 > ratios > FCF
-28151000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
62638000
Annuals > 1 > income Statement > operating Income
-62638000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-60563000
Annuals > 1 > income Statement > net Income
-60360000
Annuals > 1 > income Statement > eps
-1.8255484599641738
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
33064036
Annuals > 1 > income Statement > income Tax Expense
-203000
Annuals > 1 > income Statement > EBITDA
-62638000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
2075000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
99806000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
100843000
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
100843000
Annuals > 1 > balance Sheet > payables
2749000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
21292000
Annuals > 1 > balance Sheet > equity
59330000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-60563000
Annuals > 1 > cash Flow > depreciation
0
Annuals > 1 > cash Flow > change In Working Capital
5116000
Annuals > 1 > cash Flow > cash From Operations
-15054000
Annuals > 1 > cash Flow > capital Expenditures
8000000
Annuals > 1 > cash Flow > cash From Investing
-8000000
Annuals > 1 > cash Flow > cash From Financing
121293000
Annuals > 1 > cash Flow > net Change In Cash
98239000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.8255484599641738
Annuals > 1 > ratios > PB
2.9424930065734034
Annuals > 1 > ratios > ROE
-101.73605258722401
Annuals > 1 > ratios > ROA
-59.855418819352856
Annuals > 1 > ratios > FCF
-23054000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
27162000
Annuals > 2 > income Statement > operating Income
-27162000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-27333000
Annuals > 2 > income Statement > net Income
-25738000
Annuals > 2 > income Statement > eps
-1.4920579710144928
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
17250000
Annuals > 2 > income Statement > income Tax Expense
-570
Annuals > 2 > income Statement > EBITDA
-27162000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-171000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1567000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
1776000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
5262000
Annuals > 2 > balance Sheet > payables
2010000
Annuals > 2 > balance Sheet > short Term Debt
7756000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
27318000
Annuals > 2 > balance Sheet > equity
-32056000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-27333000
Annuals > 2 > cash Flow > depreciation
228485
Annuals > 2 > cash Flow > change In Working Capital
3541000
Annuals > 2 > cash Flow > cash From Operations
-1202000
Annuals > 2 > cash Flow > capital Expenditures
12000000
Annuals > 2 > cash Flow > cash From Investing
-12000000
Annuals > 2 > cash Flow > cash From Financing
14769000
Annuals > 2 > cash Flow > net Change In Cash
1567000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.4920579710144928
Annuals > 2 > ratios > PB
-2.841277763913152
Annuals > 2 > ratios > ROE
80.29074120289494
Annuals > 2 > ratios > ROA
-489.12960851387305
Annuals > 2 > ratios > FCF
-13202000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
1091986
Annuals > 3 > income Statement > operating Income
-1091986
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
8416710
Annuals > 3 > income Statement > net Income
8416710
Annuals > 3 > income Statement > eps
0.48792521739130434
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
17250000
Annuals > 3 > income Statement > income Tax Expense
-236558
Annuals > 3 > income Statement > EBITDA
8416710
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
9508697
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
729223
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1152117
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
140551171
Annuals > 3 > balance Sheet > payables
7000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10352192
Annuals > 3 > balance Sheet > equity
130198979
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
8416710
Annuals > 3 > cash Flow > depreciation
236558
Annuals > 3 > cash Flow > change In Working Capital
-235602
Annuals > 3 > cash Flow > cash From Operations
-1098146
Annuals > 3 > cash Flow > capital Expenditures
4
Annuals > 3 > cash Flow > cash From Investing
-139380000
Annuals > 3 > cash Flow > cash From Financing
141207369
Annuals > 3 > cash Flow > net Change In Cash
729223
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.48792521739130434
Annuals > 3 > ratios > PB
0.6995446561835175
Annuals > 3 > ratios > ROE
6.464497697789167
Annuals > 3 > ratios > ROA
5.988359926222173
Annuals > 3 > ratios > FCF
-1098150
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
67
Valuation > metrics > PE
-0.21188682889391458
Valuation > metrics > PB
4.612781029350629
Valuation > final Score
33.872189706493714
Valuation > verdict
53.8% Overvalued
Profitability > metrics > ROE
-18.511127740361964
Profitability > metrics > ROA
-14.081606836645772
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.23549790748593444
Risk > metrics > Interest Coverage
-1394.2142857142858
Risk > final Score
-5517
Risk > verdict
High
Liquidity > metrics > Current Ratio
43.44793893129771
Liquidity > metrics > Quick Ratio
43.44793893129771
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40.45820601882371
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
25
Prev Risks > 1
17
Prev Risks > 2
-12526
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:52:06.736Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.17
Earnings History > 0 > eps Estimate
-0.31
Earnings History > 0 > eps Difference
0.14
Earnings History > 0 > surprise Percent
45.1613
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.17
Earnings History > 1 > eps Estimate
-0.3
Earnings History > 1 > eps Difference
0.13
Earnings History > 1 > surprise Percent
43.3333
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.19
Earnings History > 2 > eps Estimate
-0.29
Earnings History > 2 > eps Difference
0.1
Earnings History > 2 > surprise Percent
34.4828
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-25
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.1
Earnings History > 3 > eps Estimate
-0.24
Earnings History > 3 > eps Difference
0.14
Earnings History > 3 > surprise Percent
58.3333
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.26
Earnings History > 4 > eps Estimate
-0.13
Earnings History > 4 > eps Difference
-0.13
Earnings History > 4 > surprise Percent
-100
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.17
Earnings History > 5 > eps Estimate
-0.15
Earnings History > 5 > eps Difference
-0.02
Earnings History > 5 > surprise Percent
-13.3333
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.02
Earnings History > 6 > eps Estimate
-0.23
Earnings History > 6 > eps Difference
0.21
Earnings History > 6 > surprise Percent
91.3043
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.19
Earnings History > 7 > eps Estimate
-0.23
Earnings History > 7 > eps Difference
0.04
Earnings History > 7 > surprise Percent
17.3913
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.18
Earnings History > 8 > eps Estimate
-0.25
Earnings History > 8 > eps Difference
0.07
Earnings History > 8 > surprise Percent
28
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.31
Earnings History > 9 > eps Estimate
-0.25
Earnings History > 9 > eps Difference
-1.06
Earnings History > 9 > surprise Percent
-424
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-2.7577
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-28
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.04
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.04
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.03
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.13
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-04-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.05
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2021-12-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.0474
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-19
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.35
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-27
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33 to prevent ST2-dependent and ST2-independent inflammation, which has completed Phase 1/2 clinical studies; and Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor alpha chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways, which has completed Phase 1/1b clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AZura Bio stock jumps after CEO appointment from Tourmaline Bio By Investing.com Investing.com India
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$15.6
Analyst Picks
Strong Buy
5
Buy
1
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Zura Bio Limited Class A Ordinary Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.17
EPS Estimate
-0.31
EPS Difference
0.14
Surprise Percent
45.1613%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.